Food and Drug Administration Overdose Prevention Framework (Oct 1, 2022 10:56)
Working across the Agency, FDA’s Overdose Prevention priorities closely align with HHS ...

Completed PDUFA VI Deliverables (Sep 30, 2022 20:30)
Completed PDUFA VI Deliverables

PDUFA VI Commitment: Assessment in Support of Sentinel System (Sep 30, 2022 20:27)
External Sentinel Assessment Report

BD Announces Voluntary Recall of ChloraPrep™ 3 mL Applicator in Specific U.S. Territories and Countries (Sep 30, 2022 16:38)
BD (Becton, Dickinson and Company), a leading global medical technology company, announ...

Innovation to Respond to COVID-19 (Sep 30, 2022 15:39)
Learn about FDA’s innovative approaches to respond to COVID-19 as quickly and safely as...

Oncology (Cancer) / Hematologic Malignancies Approval Notifications (Sep 30, 2022 14:48)
Oncology (Cancer) / Hematologic Malignancies Approval Notifications

FDA grants accelerated approval to futibatinib for cholangiocarcinoma (Sep 30, 2022 14:48)
On September 30, 2022, the Food and Drug Administration granted accelerated approval to...

Powered by Feed Informer